Immunization Effects of a Novel α-Synuclein-Based Peptide Epitope Vaccine in Parkinson’s Disease-Associated Pathology
Jun Sung Park, Riaz Ahmad, Kyonghwan Choe, Min Hwa Kang, Tae Ju Park, Myeong Ok Kim, Rajan Kumar Pandey · 2023
Read Immunization Effects of a Novel α-Synuclein-Based Peptide Epitope Vaccine in Parkinson’s Disease-Associated Pathology by Jun Sung Park, Riaz Ahmad, Kyonghwan Choe, Min Hwa Kang, Tae Ju Park, Myeong Ok Kim, Rajan Kumar Pandey (2023) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10748214.txt.
Description
Park and co-authors vaccinate mice against the protein that clumps in Parkinson's disease. The vaccine is a small peptide piece of alpha-synuclein, designed by computer to be safe, and it is hitched to carrier proteins that make the immune system notice it. Mice modeling the disease receive the shots, with and without carriers.
Vaccinated mice move better, and the carrier versions work best. Their blood carries more protective antibody, their brains hold less alpha-synuclein, and markers of dopamine handling recover toward normal. Brain inflammation also quiets, with calmer microglia and fewer inflammatory signals. The authors argue that epitope vaccination with carriers deserves development as a preventive strategy against Parkinson's pathology.
Catalog record
| CREATOR | Jun Sung Park, Riaz Ahmad, Kyonghwan Choe, Min Hwa Kang, Tae Ju Park, Myeong Ok Kim, Rajan Kumar Pandey |
|---|---|
| YEAR | 2023 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |